Mutational processes shape the landscape of TP53 mutations in human cancer.
Saved in:
| Title: | Mutational processes shape the landscape of TP53 mutations in human cancer. |
|---|---|
| Authors: | Giacomelli AO; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Yang X; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lintner RE; Broad Institute of MIT and Harvard, Cambridge, MA, USA., McFarland JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Duby M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kim J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Howard TP; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Takeda DY; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Ly SH; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kim E; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Gannon HS; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hurhula B; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sharpe T; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Goodale A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Fritchman B; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Steelman S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Vazquez F; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tsherniak A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Aguirre AJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Doench JG; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Piccioni F; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Roberts CWM; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Meyerson M; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Center for Cancer Research, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Johannessen CM; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hahn WC; Dana-Farber Cancer Institute, Boston, MA, USA. william_hahn@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. william_hahn@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. william_hahn@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. william_hahn@dfci.harvard.edu. |
| Source: | Nature genetics [Nat Genet] 2018 Oct; Vol. 50 (10), pp. 1381-1387. Date of Electronic Publication: 2018 Sep 17. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
